PECAM-1 / CD31 Monoclonal Antibody LS-C40811 from LSBio | Biocompare.com

Supplier Images

PECAM-1 / CD31 Monoclonal Antibody
PECAM-1 / CD31 Monoclonal Antibody

PECAM-1 / CD31 Monoclonal Antibody

Be the first to write a review!

Citations:

Supplier Page from
LSBio for
PECAM-1 / CD31 Monoclonal Antibody

LSBio's PECAM-1 / CD31 Monoclonal Antibody is a Mouse monoclonal antibody. It reacts with Homo Sapiens, Human, and Non-Human Primate. This antibody has been shown to work in applications such as: Flow Cytometry, Immunofluorescence, Immunohistochemistry, and Immunohistochemistry - frozen.

Product Specs
ItemPECAM-1 / CD31 Monoclonal Antibody
CompanyLSBio
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberLS-C40811
Quantity25 µg
ApplicationsFlo, IF, IHC, IHC-Fr
Conjugate/TagUnconjugated
FormatPBS, pH 7.2, 0.09% sodium azide
PurityAffinity purified
ReactivityHuman,Monkey,Baboon
TargetPECAM-1 / CD31
IsotypeIgG1
CloneWM59
HostMouse
NCBI Full Gene Nameplatelet and endothelial cell adhesion molecule 1
NCBI Gene AliasesCD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM
ClonalityMonoclonal

Specifications/Features

Specificity: Clone WM59 has been reported to recognize the D2 extracellular portion of CD31

Add to Compare List

LSBio

LSBio

2 Shaker Road, Unit B101

Shirley, MA 01464

United States

Phone: 206-374-1102
Fax: 206-464-1723

Company Profile

Website: http://www.lsbio.com/

(1) Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growthClinical cancer research : an official journal of the American Association for Cancer ResearchJanuary 15, 2012Wicki A, Rochlitz C, Orleth A, Ritschard R, Albrecht I, Herrmann R, Christofori G, Mamot C.

(2) Identification of functional endothelial progenitor cells suitable for the treatment of ischemic tissue using human umbilical cord bloodBloodJuly 1, 2007Nagano M, Yamashita T, Hamada H, Ohneda K, Kimura K, Nakagawa T, Shibuya M, Yoshikawa H, Ohneda O.

(3) Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endotheliumFEBS lettersMay 9, 2005MacFadyen JR, Haworth O, Roberston D, Hardie D, Webster MT, Morris HR, Panico M, Sutton-Smith M, Dell A, van der Geer P, et al.

Be the First to Write a Review!